Sedentary life impairs self-reparative processes in the brain: The role of serum insulin-like growth factor-I

Reviews in the Neurosciences

Volumn 13, Issue 4, 2002, Pages 365-374

  Trejo, Jose Luis ^a,b   Carro, Eva ^a,b   Nuñez, Angel ^b   Torres Aleman, Ignacio ^a,b  

^a INSTITUTO CAJAL   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Insulin like growth factor I; Neurodegeneration; Neuroprotection; Physical exercise; Risk factors; Sedentarism

Indexed keywords

NEUROTROPHIC FACTOR; SOMATOMEDIN C;

BRAIN FUNCTION; BRAIN TISSUE; CLINICAL TRIAL; COGNITION; CULTURAL ANTHROPOLOGY; DEGENERATIVE DISEASE; ENDOCRINE FUNCTION; ENERGY; EXERCISE; HOMEOSTASIS; HORMONE ACTION; HUMAN; IMMOBILIZATION; INSULIN BLOOD LEVEL; LIFESTYLE; LONG TERM EXPOSURE; METABOLIC ACTIVATION; NERVE CELL EXCITABILITY; NERVE CELL PLASTICITY; NEUROPROTECTION; PARACRINE SIGNALING; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SYNTHESIS; REVIEW; SIGNAL PROCESSING; SIGNAL TRANSDUCTION; TARGET CELL; TISSUE REPAIR;

EID: 0036933516     PISSN: 03341763     EISSN: None     Source Type: Journal    
DOI: 10.1515/REVNEURO.2002.13.4.365     Document Type: Review

References (92)

1. Aberg MA, Aberg ND, Hedbacker H, Oscarsson J, Eriksson PS. Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus. J Neurosci 2000; 20: 2896-2903.
2. Amaducci L, Tesco G. Aging as a major risk for degenerative diseases of the central nervous system. Curr Opin Neurol 1994; 7: 283-286.
3. Anderson MF, Aberg MA, Nilsson M, Eriksson PS. Insulin-like growth factor-I and neurogenesis in the adult mammalian brain. Brain Res Dev Brain Res 2002; 134: 115-122.
4. Anlar B, Sullivan KA, Feldman EL. Insulin-like growth factor-I and central nervous system development. Horm Metab Res 1999; 31: 120-125.
5. Anthony TG, Anthony JC, Lewitt MS, Donovan SM, Layman DK. Time course changes in IGFBP-1 after treadmill exercise and postexercise food intake in rats. Am J Physiol Endocrinol Metab 2001; 280: E650-E656.
6. Auletta M, Nielsen FC, Gammeltoft S. Receptormediated endocytosis and degradation of insulin-like growth factor I and II in neonatal rat astrocytes. J Neurosci Res 1992; 31: 14-20.
7. Banks WA, Jaspan JB, Kastin AJ. Selective, physiological transport of insulin across the blood-brain barrier: Novel demonstration by species-specific radioimmunoassays. Peptides 1997; 18: 1257-1262.
8. Bastian SE, Walton PE, Belford DA. Paracellular transport of insulin-like growth factor-I (IGF-I) across human umbilical vein endothelial cell monolayers. J Cell Physiol 1997; 170: 290-298.
9. Baulieu EE, Robel P, Schumacher M. Neurosteroids: Beginning of the story. Int Rev Neurobiol 2001; 46: 1-32.
10. Beck KD, Powell-Braxton L, Widmer HR, Valverde J, Hefti F. Igf1 gene disruption results in reduced brain size, CNS hypomyelination, and loss of hippocampal granule and striatal parvalbumin-containing neurons. Neuron 1995; 14: 717-730.
11. Bilak MM, Kuncl RW. Delayed application of IGF-I and GDNF can rescue already injured postnatal motor neurons. NeuroReport 2001; 12: 2531-2535.
12. Blum-Degen D, Frolich L, Hoyer S, Riederer P. Altered regulation of brain glucose metabolism as a cause of neurodegenerative disorders? J Neural Transm 1995; 46 (Suppl): 139-147.
13. Bondy CA, Lee WH. Patterns of insulin-like growth factor and IGF receptor gene expression in the brain. Functional implications. Ann NY Acad Sci 1993; 692: 33-43.
14. Booth FW, Chakravarthy MV, Gordon SE, Spangenburg EE. Waging war on physical inactivity: Using modern molecular ammunition against an ancient enemy. J Appl Physiol 2002; 93: 3-30.
15. Booth FW, Chakravarthy MV, Spangenburg EE. Exercise and gene expression: Physiological regulation of the human genome through physical activity. J Physiol 2002; 543: 399-411.
16. Busiguina S, Fernandez AM, Barrios V, et al. Neurodegeneration is associated to changes in serum insulin-like growth factors. Neurobiol Dis 2000; 7: 657-665.
17. Carro E, Nunez A, Busiguina S, Torres-Aleman I. Circulating insulin-like growth factor I mediates effects of exercise on the brain. J Neurosci 2000; 20: 2926-2933.
18. Carro E, Trejo JL, Busiguina S, Torres-Aleman I. Circulating insulin-like growth factor I mediates the protective effects of physical exercise against brain insults of different etiology and anatomy. J Neurosci 2001; 21: 5678-5684.
19. Carson MJ, Behringer RR, Brinster RL, McMorris FA. Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Neuron 1993; 10: 729-740.
20. Cheng CM, Cohen M, Tseng V, Bondy CA. Endogenous IGF1 enhances cell survival in the postnatal dentate gyrus. J Neurosci Res 2001; 64: 341-347.
21. Cheng CM, Reinhardt RR, Lee WH, Joncas G, Patel SC, Bondy CA. Insulin-like growth factor I regulates developing brain glucose metabolism. Proc Natl Acad Sci USA 2000; 97: 10236-10241.
22. Chrysis D, Calikoglu AS, Ye P, D'Ercole AJ. Insulinlike growth factor-I overexpression attenuates cerebellar apoptosis by altering the expression of Bcl family proteins in a developmentally specific manner. J Neurosci 2001; 21: 1481-1489.
23. Cotman CW, Berchtold NC. Exercise: A behavioral intervention to enhance brain health and plasticity. Trends Neurosci 2002; 25: 295-301.
24. Craft S, Peskind E, Schwartz MW, Schellenberg GD, Raskind M, Porte D Jr. Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: Relationship to severity of dementia and apolipoprotein E genotype. Neurology 1998; 50: 164-168.
25. D'Ercole AJ, Ye P, Calikoglu AS, Gutierrez-Ospina G. The role of the insulin-like growth factors in the central nervous system. Mol Neurobiol 1996; 13: 227-255.
26. Daughaday WH, Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 1989; 10: 68-91.
27. de Pablo F, de la Rosa EJ. The developing CNS: A scenario for the action of proinsulin, insulin and insulinlike growth factors. Trends Neurosci 1995; 18: 143-150.
28. DeBosch BJ, Baur E, Deo BK, Hiraoka M, Kumagai AK. Effects of insulin-like growth factor-1 on retinal endothelial cell glucose transport and proliferation. J Neurochem 2001; 77: 1157-1167.
29. Desai NS, Cudmore RH, Nelson SB, Turrigiano GG. Critical periods for experience-dependent synaptic scaling in visual cortex. Nat Neurosci 2002; 5: 783-789.
30. Deuschle M, Blum WF, Frystyk J, et al. Endurance training and its effect upon the activity of the GH-IGFs system in the elderly. Int J Sports Med 1998; 19: 250-254.
31. Doering TJ, Resch KL, Steuernagel B, Brix J, Schneider B, Fischer GC. Passive and active exercises increase cerebral blood flow velocity in young, healthy individuals. Am J Phys Med Rehabil 1998; 77: 490493.
32. Dore S, Kar S, Quirion R. Rediscovering an old friend, IGF-I: Potential use in the treatment of neurodegenerative diseases. Trends Neurosci 1997; 20: 326-331.
33. Dringen R, Hamprecht B. Glucose, insulin, and insulinlike growth factor I regulate the glycogen content of astroglia-rich primary cultures. J Neurochem 1992; 58: 511-517.
34. Dudek H, Datta SR, Franke TF, et al. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 1997; 275: 661-665.
35. Dunn SE. Insulin-like growth factor I stimulates angiogenesis and the production of vascular endothelial growth factor. Growth Horm IGF Res 2000; 10 (Suppl A): S41-S42.
36. Eliakim A, Brasel JA, Cooper DM. GH response to exercise: Assessment of the pituitary refractory period, and relationship with circulating components of the GH-IGF-I axis in adolescent females. J Pediatr Endocrinol Metab 1999; 12: 47-55.
37. Eliakim A, Brasel JA, Mohan S, Wong WL, Cooper DM. Increased physical activity and the growth hormone-IGF-I axis in adolescent males. Am J Physiol 1998; 275: R308-R314.
38. Eliakim A, Moromisato M, Moromisato D, Brasel JA, Roberts C, Cooper DM. Increase in muscle IGF-I protein but not IGF-I mRNA after 5 days of endurance training in young rats. Am J Physiol 1997; 273: R1557-R1561.
39. Fernandez AM, de la Vega AG, Torres-Aleman I. Insulin-like growth factor I restores motor coordination in a rat model of cerebellar ataxia. Proc Natl Acad Sci USA 1998; 95: 1253-1258.
40. Friedlander AL, Butterfield GE, Moynihan S, et al. One year of insulin-like growth factor I treatment does not affect bone density, body composition, or psychological measures in postmenopausal women. J Clin Endocrinol Metab 2001; 86: 1496-1503.
41. Garcia-Segura LM, Rodriguez JR, Torres-Aleman I. Localization of the insulin-like growth factor I receptor in the cerebellum and hypothalamus of adult rats: An electron microscopic study. J Neurocytol 1997; 26: 479-490.
42. Gasparini L, Gouras GK, Wang R, et al. Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling. J Neurosci 2001; 21: 2561-2570.
43. George M, Ayuso E, Casellas A, Costa C, Devedjian JC, Bosch F. Beta cell expression of IGF-I leads to recovery from type 1 diabetes. J Clin Invest 2002; 109: 1153-1163.
44. Guan J, Miller OT, Waugh KM, McCarthy DC, Gluckman PD. Insulin-like growth factor-1 improves somatosensory function and reduces the extent of cortical infarction and ongoing neuronal loss after hypoxia-ischemia in rats. Neuroscience 2001; 105: 299-306.
45. Hantai D, Akaaboune M, Lagord C, et al. Beneficial effects of insulin-like growth factor-I on wobbler mouse motoneuron disease. J Neurol Sci 1995; 129 (Suppl): 122-126.
46. Hoyer S. The aging brain. Changes in the neuronal insulin/insulin receptor signal transduction cascade trigger late-onset sporadic Alzheimer disease (SAD). A mini-review. J Neural Transm 2002; 109: 991-1002.
47. Humbert S, Bryson EA, Cordelieres FP, et al. The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt. Dev Cell 2002; 2: 831-837.
48. Jain S, Golde DW, Bailey R, Geffner ME. Insulin-like growth factor-I resistance. Endocr Rev 1998; 19: 625-646.
49. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: Biological actions. Endocr Rev 1995; 16: 3-34.
50. Lee WH, Michels KM, Bondy CA. Localization of insulin-like growth factor binding protein-2 messenger RNA during postnatal brain development: Correlation with insulin-like growth factors I and II. Neuroscience 1993; 53: 251-265.
51. Leifke E, Gorenoi V, Wichers C, Von Zur MA, Von Buren E, Brabant G. Age-related changes of serum sex hormones, insulin-like growth factor-1 and sex-hormone binding globulin levels in men: Cross-sectional data from a healthy male cohort. Clin Endocrinol (Oxf) 2000; 53: 689-695.
52. Lommatzsch M, Braun A, Mannsfeldt A, et al. Abundant production of brain-derived neurotrophic factor by adult visceral epithelia. Implications for paracrine and target-derived neurotrophic functions. Am J Pathol 1999; 155: 1183-1193.
53. McRory JE, Sherwood NM. Ancient divergence of insulin and insulin-like growth factor. DNA Cell Biol 1997; 16: 939-949.
54. Muller G, Grey S, Jung C, Bandlow W. Insulin-like signaling in yeast: Modulation of protein phosphatase 2A, protein kinase A, cAMP-specific phosphodiesterase, and glycosyl-phosphatidylinositol-specific phospho-lipase C activities. Biochemistry 2000; 39: 1475-1488.
55. Musaro A, McCullagh K, Paul A, et al. Localized Igf-I transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nat Genet 2001; 27: 195-200.
56. Mustafa A, Lannfelt L, Lilius L, Islam A, Winblad B, Adem A. Decreased plasma insulin-like growth factor-I level in familial Alzheimer's disease patients carrying the Swedish APP 670/671 mutation. Dement Geriatr Cogn Disord 1999; 10: 446-451.
57. Niikura T, Hashimoto Y, Okamoto T, et al. Insulin-like growth factor I (IGF-I) protects cells from apoptosis by Alzheimer's V642I mutant amyloid precursor protein through IGF-I receptor in an IGF-binding protein-sensitive manner. J Neurosci 2001; 21: 1902-1910.
58. O'Kusky JR, Ye P, D'Ercole AJ. Insulin-like growth factor-I promotes neurogenesis and synaptogenesis in the hippocampal dentate gyrus during postnatal development. J Neurosci 2000; 20: 8435-8442.
59. Ono M, Itakura Y, Nonomura T, et al. Intermittent administration of brain-derived neurotrophic factor ameliorates glucose metabolism in obese diabetic mice. Metabolism 2000; 49: 129-133.
60. Pan W, Banks WA, Kastin AJ. Permeability of the blood-brain barrier to neurotrophins. Brain Res 1998; 788: 87-94.
61. Peters A, Schweiger U, Fruhwald-Schultes B, Born J, Fehm HL. The neuroendocrine control of glucose allocation, Exp Clin Endocrinol Diabetes 2002; 110: 199-211.
62. Poduslo JF, Curran GL, Berg CT, Macromolecular permeability across the blood-nerve and blood-brain barriers. Proc Natl Acad Sci USA 1994; 91: 5705-5709.
63. Pulford BE, Whalen LR, Ishii DN. Peripherally administered insulin-like growth factor-I preserves hindlimb reflex and spinal cord noradrenergic circuitry following a central nervous system lesion in rats, Exp Neurol 1999; 159: 114-123.
64. Reiber H, Dynamics of brain-derived proteins in cerebrospinal fluid. Clin Chim Acta 2002; 310: 173-186.
65. Reinecke M, Collet C. The phylogeny of the insulin-like growth factors. Int Rev Cytol 1998; 183: 1-94.
66. Reinhardt RR, Bondy CA. Insulin-like growth factors cross the blood-brain barrier. Endocrinology 1994; 135: 1753-1761.
67. Roelen CA, de Vries WR, Koppeschaar HP, Vervoorn C, Thijssen JH, Blankenstein MA. Plasma insulin-like growth factor-I and high affinity growth hormone-binding protein levels increase after two weeks of strenuous physical training, Int J Sports Med 1997; 18: 238-241.
68. Rosenfeld RD, Zeni L, Haniu M, et al. Purification and identification of brain-derived neurotrophic factor from human serum. Protein Express Purif 1995; 6: 465-471.
69. Rubin LL, Staddon JM. The cell biology of the bloodbrain barrier. Annu Rev Neurosci 1999; 22: 11-28.
70. Rulifson EJ, Kim SK, Nusse R. Ablation of insulin-producing neurons in flies: Growth and diabetic phenotypes. Science 2002; 296: 1118-1120.
71. Selkoe DJ. Clearing the brain's amyloid cobwebs. Neuron 2001; 32: 177-180.
72. Semenza GL. Regulation of mammalian 02 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 1999; 15: 551-578.
73. Serrano T, Lorigados LC, Armenteros S. Nerve growth factor levels in normal human sera. NeuroReport 1996; 8: 179-181.
74. Sonntag WE, Lynch CD, Cooney PT, Hutchins PM. Decreases in cerebral microvasculature with age are associated with the decline in growth hormone and insulin-like growth factor 1. Endocrinology 1997; 138: 3515-3520.
75. Stein TD, Johnson JA. Lack of neurodegeneration in transgenic mice overexpressing mutant amyloid precursor protein is associated with increased levels of transthyretin and the activation of cell survival pathways. J Neurosci 2002; 22: 7380-7388.
76. Tham A, Nordberg A, Grissom FE, Carlsson-Skwirut C, Viitanen M, Sara VR. Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer type. J Neural Transm Park Dis Dement Sect 1993; 5: 165-176.
77. Tissandier O, Peres G, Fiet J, Piette F. Testosterone, dehydroepiandrosterone, insulin-like growth factor 1, and insulin in sedentary and physically trained aged men. Eur J Appl Physiol 2001; 85: 177-184.
78. Torres-Aleman I. Insulin-like growth factors as mediators of functional plasticity in the adult brain. Horm Metab Res 1999; 31: 114-119.
79. Torres-Aleman I. Serum growth factors and neuroprotective surveillance. Mol Neurobiol 2000; 21: 153-160.
80. Torres-Aleman I, Barrios V, Berciano J. The peripheral insulin-like growth factor system in amyotrophic lateral sclerosis and in multiple sclerosis. Neurology 1998; 50: 772-776.
81. Torres-Aleman I, Barrios V, Lledo A, Berciano J. The insulin-like growth factor I system in cerebellar degeneration. Ann Neurol 1996; 39: 335-342.
82. Torres-Aleman I, Pons S, Arevalo MA. The insulin-like growth factor I system in the rat cerebellum: Developmental regulation and role in neuronal survival and differentiation. J Neurosci Res 1994; 39: 117-126.
83. Trejo JL, Carro E, Torres-Aleman I. Circulating insulin-like growth factor I mediates exercise-induced increases in the number of new neurons in the adult hippocampus. J Neurosci 2001; 21: 1628-1634.
84. Venters HD, Tang Q, Liu Q, VanHoy RW, Dantzer R, Kelley KW. A new mechanism of neurodegeneration: A proinflammatory cytokine inhibits receptor signaling by a survival peptide. Proc Natl Acad Sci USA 1999; 96: 9879-9884.
85. Wallace JD, Cuneo RC, Baxter R, et al. Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: A potential test for GH abuse in sport. J Clin Endocrinol Metab 1999; 84: 3591-3601.
86. Wang PH. Roads to survival: Insulin-like growth factorI signaling pathways in cardiac muscle. Circ Res 2001; 88: 552-554.
87. Wang YT, Linden DJ. Expression of cerebellar longterm depression requires postsynaptic clathrin-mediated endocytosis. Neuron 2000; 25: 635-47.
88. Willis PE, Chadan S, Baracos V, Parkhouse WS. Acute exercise attenuates age-associated resistance to insulin-like growth factor I. Am J Physiol 1997; 272: E397-E404.
89. Xie L, Helmerhorst E, Taddei K, Plewright B, Van Bronswijk W, Martins R. Alzheimer's beta-amyloid peptides compete for insulin binding to the insulin receptor. J Neurosci 2002; 22: RC221.
90. Yakar S, Liu JL, Stannard B, et al. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci USA 1999; 96: 7324-7329.
91. Zapf A, Hsu D, Olefsky JM. Comparison of the intracellular itineraries of insulin-like growth factor-I and insulin and their receptors in Rat-1 fibroblasts. Endocrinology 1994; 134: 2445-2452.
92. Zelzer E, Levy Y, Kahana C, Shilo BZ, Rubinstein M, Cohen B. Insulin induces transcription of target genes through the hypoxia-inducible factor HIF-lalpha/ARNT. EMBO J 1998; 17: 5085-5094.